1. GW24-e2907 Effects of RG7652, a fully human mAb against proprotein convertase subtilisin/kexin type 9, on LDL-c: a Phase I, randomised, double-blind, placebo-controlled, single- and multiple-dose study. (1st October 2013) Authors: Tingley, Whittemore; Luca, Diana; Leabman, Maya; Budha, Nageshwar; Kahn, Robert; Baruch, Amos; Cowan, Kyra; Davis, John C Journal: Heart Issue: Volume 99(2013)Supplement 3 Page Start: A153 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗